↓ Skip to main content

Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR mutant lung cancer

Overview of attention for article published in Journal of Clinical Investigation, July 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

news
3 news outlets
twitter
11 X users

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 31 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 6 19%
Student > Ph. D. Student 4 13%
Student > Master 3 10%
Student > Doctoral Student 2 6%
Student > Bachelor 2 6%
Other 3 10%
Unknown 11 35%
Readers by discipline
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 10 32%
Medicine and Dentistry 4 13%
Immunology and Microbiology 3 10%
Agricultural and Biological Sciences 2 6%
Nursing and Health Professions 1 3%
Other 0 0%
Unknown 11 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 29. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 March 2023.
All research outputs
#1,650,497
of 32,432,086 outputs
Outputs from Journal of Clinical Investigation
#2,068
of 20,159 outputs
Outputs of similar age
#30,138
of 455,507 outputs
Outputs of similar age from Journal of Clinical Investigation
#31
of 121 outputs
Altmetric has tracked 32,432,086 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,159 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.1. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 455,507 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 121 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.